NLG802: An Oral Prodrug of IDO1 Inhibitor
NLG802
oral prodrug of IDO1 inhibitor completed Ph. I in solid tumors from derivatization of indoximod Eur. J. Med. Chem., May 1, 2020 NewLink Genetics, Ames, IA
Loading...
oral prodrug of IDO1 inhibitor completed Ph. I in solid tumors from derivatization of indoximod Eur. J. Med. Chem., May 1, 2020 NewLink Genetics, Ames, IA